Ligand validation:7EC0

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 7EC0 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7EC0_SAH_D_301	62%	54%	0.164	0.957	0.87	0.9	2	2	2	0	100%	1
7EC0_SAH_M_301	57%	55%	0.155	0.929	0.81	0.92	2	2	1	0	100%	1
7EC0_SAH_G_301	56%	51%	0.178	0.95	0.92	0.99	2	2	0	0	100%	1
7EC0_SAH_J_301	43%	52%	0.223	0.95	0.86	1	2	2	6	0	100%	1
7EC0_SAH_A_301	8%	59%	0.342	0.816	0.73	0.85	1	1	4	0	100%	0.5
7EBX_SAH_A_301	35%	58%	0.224	0.913	0.75	0.86	-	2	2	0	100%	0.92
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1
8TE4_SAH_B_1001	100%	24%	0.031	0.994	1.26	1.81	3	4	0	0	100%	1
8TE3_SAH_C_1001	100%	24%	0.033	0.995	1.27	1.84	3	4	1	0	100%	1
8TE1_SAH_D_1001	100%	25%	0.034	0.992	1.25	1.81	3	4	0	0	100%	1
5PA0_SAH_A_301	100%	32%	0.043	0.994	1.11	1.59	2	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.